Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation

Sora Lee1, Brian T Craig1, Carmelle V Romain1

  • 1Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Cancer Letters
|September 30, 2014
PubMed

Insights

Increased cell division cycle 42 (CDC42) expression correlates with aggressive neuroblastoma. Inhibiting CDC42 reduced tumor cell growth and increased cell death, suggesting CDC42 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cell division cycle 42 (CDC42) is a Rho-subfamily GTPase involved in cell proliferation, cytoskeletal dynamics, and malignant transformation.
  • Aberrant CDC42 expression is implicated in various cancers, but its specific role in neuroblastoma progression remains unclear.

Purpose of the Study:

  • To investigate the role of CDC42 in the pathogenesis and progression of neuroblastoma.
  • To determine if CDC42 expression levels correlate with neuroblastoma differentiation and aggressiveness.
  • To evaluate the therapeutic potential of targeting CDC42 in neuroblastoma cell lines.

Main Methods:

  • Quantitative analysis of CDC42 expression in neuroblastoma cell lines with varying differentiation states.
  • Inhibition of CDC42 activity using pharmacological inhibitors or gene silencing (siRNA).
  • Assessment of cell proliferation, colony formation in soft agar, apoptosis, and N-myc expression following CDC42 manipulation.

Main Results:

  • Elevated CDC42 expression was observed in undifferentiated, aggressive neuroblastoma cells compared to more benign phenotypes.
  • CDC42 inhibition significantly reduced cell growth and soft agar colony formation in aggressive neuroblastoma cell lines (BE(2)-C, BE(2)-M17).
  • Silencing CDC42 led to increased cell death and decreased expression of the oncogene N-myc in sensitive cell lines.

Conclusions:

  • CDC42 plays a critical role in promoting the aggressive behavior of certain neuroblastoma subtypes.
  • Targeting CDC42 may represent a viable therapeutic strategy for aggressive neuroblastoma.
  • The findings highlight CDC42 as a potential biomarker for neuroblastoma prognosis and a therapeutic target.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K